Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Offer Update

5 Mar 2010 07:00

RNS Number : 1229I
Proximagen Neuroscience Plc
05 March 2010
 



 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO.

 

For immediate release

5 March 2010

 

RECOMMENDED CASH OFFER FOR THE

 

ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL

 

OF MINSTER PHARMACEUTICALS PLC

 

BY PROXIMAGEN NEUROSCIENCE PLC

 

Compulsory Acquisition of Outstanding Minster Pharmaceuticals plc Shares

 

On 4 January 2010, the boards of Proximagen Neuroscience plc ("Proximagen") and Minster Pharmaceuticals plc ("Minster") announced the recommended offer by Proximagen for the entire issued and to be issued share capital of Minster (the "Offer"). On 17 February 2010 Proximagen announced that, as at 1.00 p.m. on 16 February 2010 (the "First Closing Date"), valid acceptances of the Offer had been received in respect of a total of 50,805,875 Minster Shares representing approximately 86.25 per cent. of the entire issued share capital of Minster and declared the Offer to be unconditional as to acceptances. As at 1.00p.m. on 4 March 2010, valid acceptance of the Offer had been received in respect of a total of 64,929,488 Minster Shares representing approximately 91.26 per cent of the entire issued share capital of Minster.

 

These acceptances include acceptances received in respect of 32,891,853* Minster Shares (representing approximately 55.84 per cent. of the existing issued share capital of Minster) which were subject to irrevocable commitments procured by Proximagen from all of the Minster Directors and certain other shareholders.

 

* The 32,891,853 Minster Shares subject to irrevocable commitments as set out above, differs by 200 Minster Shares from the number of Minster Shares subject to irrevocable commitments as set out in the Offer Document. The difference is due to an administrative error in the Offer Document.

 

Offer Remains Open for Acceptance

 

The Offer will remain open until further notice.

 

To accept the Offer:

 

·; If you hold Minster Shares in certificated form (that is, not in CREST), the form of acceptance should be completed, signed, witnessed and returned together with your share certificate in accordance with the instructions contained in the Offer Document and the form of acceptance.

 

·; If you hold Minster Shares in uncertificated form (that is, in CREST), you should follow the procedure for electronic acceptance through CREST in accordance with the instructions set out in the Offer Document.

 

Settlement

 

Settlement of the consideration to which Minster Shareholders are entitled under the Offer will be effected by the despatch of cheques or the crediting of CREST accounts:

 

(i) in the case of acceptances received, valid and complete in all respects, on or before 4 March 2010, as soon as possible but not later than 14 days of such date; and

 

(ii) in the case of acceptances received, valid and complete in all respects, after such date but while the Offer remains open for acceptance, as soon as possible but not later than within 14 days of such receipt.

 

Compulsory acquisition procedure

 

As described in the Offer Document, as an acceptance level of not less than 90 per cent. has been reached, Proximagen is now entitled to apply the provisions of Chapter 3 of Part 28 of the Companies Act to acquire compulsorily any remaining Minster Shares in respect of which acceptances have not then been received, on the same terms as the Offer. Proximagen will write to Minster Shareholders individually to notify them of the commencement of the compulsory acquisition procedure, which does not affect their right to accept the Offer in the normal way whilst it remains open for acceptance.

 

Cancellation to trading of Minster Shares on AIM

 

On 17 February 2010 Proximagen announced that it had procured the making of an application by Minister to cancel admission to trading in Minster Shares on AIM. Such cancellation is anticipated to take place at 7.00 a.m. on 18 March 2010.

 

A copy of this announcement, the Offer Document and the form of acceptance are available free of charge to view, subject to restrictions relating to persons located in jurisdictions where such availability is restricted, on Proximagen's website at www.proximagen.com and on Minster's website at www.minsterpharma.com. In addition, copies of the Offer Document and form of acceptance will be available from the offices of Capita Registrars, Corporate Actions, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.

 

Terms defined in the Offer Document have the same meaning in this announcement.

 

5 March 2010

 

Enquiries:

 

For Proximagen

Proximagen Neuroscience plc

Phone: +44 (0)20 7848 6938

Kenneth Mulvany, Chief Executive Officer

James Hunter, Finance Director

Pelham Bell Pottinger

Phone: +44 (0)20 7861 3800

Charles Cook, Dan de Belder, Zoë Pocock

Evolution Securities Limited (NOMAD)

Phone: +44 (0)20 7071 4300

Stuart Andrews, Bobbie Hilliam, Tim Redfern

For Minster:

Minster Pharmaceuticals plc

Phone: +44 (0)20 7848 6938

Kenneth Mulvany, Director

James Hunter, Director

Buchanan Communications

Phone: +44 (0)20 7466 5000

Mark Court

Nomura Code Securities Limited

(Rule 3 Advisers & NOMAD)

Phone: +44 (0)20 7776 1200

Richard Potts, Giles Balleny

 

This announcement is not intended to, and does not constitute, or form any part of an offer to sell or an invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or the solicitation of an offer to purchase or subscribe for any securities in any jurisdiction, pursuant to the Offer or otherwise. Any acceptance or other response to the Offer should be made only on the basis of information contained in or referred to in the Offer Document and, in respect of Minster Shares held in certificated form, the form of acceptance

 

Evolution Securities Limited, which is authorised and regulated by the Financial Services Authority is acting as financial adviser and broker to Proximagen and for no-one else in connection with the Offer and will not be responsible to anyone other than Proximagen for providing the protections afforded to customers of Evolution Securities Limited or for affording advice in relation to the Offer or any other matters referred to in this document.

 

Nomura Code Securities Limited, which is authorised and regulated by the Financial Services Authority, is acting as financial adviser to Minster and for no-one else in connection with the Offer and will not be responsible to anyone other than Minster for providing the protections afforded to customers of Nomura Code Securities Limited or for affording advice in relation to the Offer or any other matters referred to in this document.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CASKKQDQABKDONK
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.